G15

CAS No. 1161002-05-6

G15( —— )

Catalog No. M20708 CAS No. 1161002-05-6

G15 is a cell-permeable non-steroidal antagonist of GPER (Ki = 20 nM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 68 In Stock
10MG 113 In Stock
25MG 205 In Stock
50MG 350 In Stock
100MG 527 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    G15
  • Note
    Research use only, not for human use.
  • Brief Description
    G15 is a cell-permeable non-steroidal antagonist of GPER (Ki = 20 nM).
  • Description
    G15 is a cell-permeable non-steroidal antagonist of GPER (Ki = 20 nM).
  • In Vitro
    Cell Proliferation Assay Cell Line:A549, H1793 cell lines Concentration:0.1, 1, 10 μM (combination with 10 nM E2)Incubation Time:2 days Result:Inhibited GPER-mediated proliferation stimulated by E2.Western Blot Analysis Cell Line:A549, H1793 cell lines Concentration:1 μM (combination with 10 nM E2 and 10 nM G1)Incubation Time:48 hours Result:Inhibited the response of GPER stimulated by E2 and G1.
  • In Vivo
    Animal Model:Four-week-old female Kunming mice (Urethane-induced adenocarcinoma) Dosage:1.46 mg/kg (combination with E2, 0.09 mg/kg and fulvestrant (Ful), 2.4 mg/kg) Administration:Subcutaneous injection; twice a week for 14 weeks Result:The number of tumor nodules decreased in the E2+Ful+G15 group.
  • Synonyms
    ——
  • Pathway
    Endocrinology/Hormones
  • Target
    Estrogen Receptor/ERR
  • Recptor
    GPER
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1161002-05-6
  • Formula Weight
    370.24
  • Molecular Formula
    C19H16BrNO2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:41.67 mg/mL (112.55 mM)
  • SMILES
    [H][C@]12CC=C[C@@]1([H])c1ccccc1N[C@H]2c1cc2OCOc2cc1Br
  • Chemical Name
    (3aS4R9bR)-4-(6-bromo-13-benzodioxol-5-yl)-3a459b-tetrahydro-3H-cyclopenta[c]quinoline

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Nayak T K Bologa C G Leitao A et al. In vivo effects of a GPR30 antagonist[J]. Nature Chemical Biology 2009 5(6):421-427.
molnova catalog
related products
  • GDC-0927 R-form

    GDC-0927 (SRN-927, RG-6047) is a potent, orally bioavailable, selective estrogen receptor degrader (SERD).

  • Medicarpin (b)

    (+)-Medicarpin potently inhibits osteoclastogenesis and promotes bone healing and increases bone mass by osteoblast differentiation with estrogen receptor (ER) β-mediated osteogenic action.

  • Pipendoxifene hydroc...

    Pipendoxifene hydrochloride is a selective modulator of estrogen receptor.